1. Home
  2. INTS vs AMZE Comparison

INTS vs AMZE Comparison

Compare INTS & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • AMZE
  • Stock Information
  • Founded
  • INTS 2012
  • AMZE 2019
  • Country
  • INTS United States
  • AMZE United States
  • Employees
  • INTS N/A
  • AMZE N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • AMZE Beverages (Production/Distribution)
  • Sector
  • INTS Health Care
  • AMZE Consumer Staples
  • Exchange
  • INTS Nasdaq
  • AMZE Nasdaq
  • Market Cap
  • INTS 12.2M
  • AMZE 12.3M
  • IPO Year
  • INTS 2023
  • AMZE 2021
  • Fundamental
  • Price
  • INTS $0.31
  • AMZE $1.87
  • Analyst Decision
  • INTS Strong Buy
  • AMZE
  • Analyst Count
  • INTS 4
  • AMZE 0
  • Target Price
  • INTS $4.50
  • AMZE N/A
  • AVG Volume (30 Days)
  • INTS 5.0M
  • AMZE 140.7K
  • Earning Date
  • INTS 11-12-2025
  • AMZE 11-13-2025
  • Dividend Yield
  • INTS N/A
  • AMZE N/A
  • EPS Growth
  • INTS N/A
  • AMZE N/A
  • EPS
  • INTS N/A
  • AMZE N/A
  • Revenue
  • INTS N/A
  • AMZE $1,054,111.00
  • Revenue This Year
  • INTS N/A
  • AMZE $6,741.66
  • Revenue Next Year
  • INTS N/A
  • AMZE $100.61
  • P/E Ratio
  • INTS N/A
  • AMZE N/A
  • Revenue Growth
  • INTS N/A
  • AMZE N/A
  • 52 Week Low
  • INTS $0.19
  • AMZE $1.57
  • 52 Week High
  • INTS $3.75
  • AMZE $28.72
  • Technical
  • Relative Strength Index (RSI)
  • INTS 64.31
  • AMZE 37.03
  • Support Level
  • INTS $0.27
  • AMZE $1.96
  • Resistance Level
  • INTS $0.30
  • AMZE $2.12
  • Average True Range (ATR)
  • INTS 0.03
  • AMZE 0.46
  • MACD
  • INTS 0.01
  • AMZE -0.04
  • Stochastic Oscillator
  • INTS 60.25
  • AMZE 12.50

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

Share on Social Networks: